Picture Berlin Partner Life Sciences Report 2019/2020 Brandenburg 650x80px
Organisation › Details

Stargazer Pharmaceutcials Inc.

Stargazer Pharmaceuticals, Inc., is a Boston-based biopharmaceutical drug development company launched in 2018 with a focus on rare diseases of the eye, and an initial focus on Stargardt Disease. *


Period Start 2018-01-01 established
Products Industry ophthalmic
  Industry 2 drug development
Region Region Boston, MA
  Country United States (USA)
  City n. a. 
    Address record changed: 2020-12-02
Basic data Employees n. a.
    * Document for �About Section�: Novo Holdings A/S. (11/9/20). "Press Release: Novo Ventures-incubated Rare Disease Company, Stargazer Pharmaceuticals, Enters Ph2 Development and Announces $57m Series A Financing". Boston, MA.
Record changed: 2020-11-11


Picture [iito] Plain Stupid Simple 650x80px

More documents for Stargazer Pharmaceutcials Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


Picture EBD Group BioTech Showcase 2021 Digital Event BTS2021 651x81

» top